Xiangshu Xiao
Affiliations: | Physiology and Pharmocology | Oregon Health and Science University, Portland, OR |
Area:
Chemical biology, organic synthesis, medicinal chemistryGoogle:
"Xiangshu Xiao"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Xie F, Martin-Acosta P, Li BX, et al. (2020) Mechanistic Insights into the Activation of Ester Prodrugs of 666-15. Bioorganic & Medicinal Chemistry Letters. 127455 |
Meng Q, Li BX, Xiao X. (2018) Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics. Frontiers in Molecular Biosciences. 5: 35 |
Li BX, Chen J, Chao B, et al. (2018) Anticancer pyrroloquinazoline LBL1 targets nuclear lamins. Acs Chemical Biology |
Xie F, Li BX, Kassenbrock A, et al. (2015) Identification of a Potent Inhibitor of CREB-Mediated Gene Transcription with Efficacious in Vivo Anticancer Activity. Journal of Medicinal Chemistry. 58: 5075-87 |
Chao B, Li BX, Xiao X. (2015) The chemistry and pharmacology of privileged pyrroloquinazolines. Medchemcomm. 6: 510-520 |
Li BX, Xie F, Fan Q, et al. (2014) Novel Type of Prodrug Activation through a Long-Range O,N-Acyl Transfer: A Case of Water-Soluble CREB Inhibitor. Acs Medicinal Chemistry Letters. 5: 1104-9 |
Chen J, Kassenbrock A, Li BX, et al. (2013) Discovery of a Potent Anti-tumor Agent through Regioselective Mono-N-acylation of 7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine. Medchemcomm. 4: 1275-1282 |
Xie F, Li BX, Broussard C, et al. (2013) Identification, synthesis and evaluation of substituted benzofurazans as inhibitors of CREB-mediated gene transcription. Bioorganic & Medicinal Chemistry Letters. 23: 5371-5 |
Mitton B, Dutta R, Hsu Y, et al. (2013) The pp90rsk-CREB Signaling Pathway Regulates Apoptosis In Acute Myelogenous Leukemia Blood. 122: 3801-3801 |
Xiao X, Li B, Xie F, et al. (2013) Abstract P4-15-08: Discovery of a potent inhibitor of CREB-mediated gene transcription that completely suppresses the growth of triple-negative breast cancer cells Cancer Research. 73 |